The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets
Article in Vascular Pharmacology (May 2023)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Treatment of pulmonary hypertension with riociguat: a review of current evidence and future perspectives
Article in Expert Opinion on Pharmacotherapy (February 2020)
Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension
Article in Drug Design Development and Therapy (April 2017)